Background and Aims It has been proposed that more use should be made of Bayes factors in hypothesis testing in ad-
INTRODUCTION
Bayesian statistical analyses are being used increasingly in addictions research, and it has been proposed that this trend should accelerate [1] . One important component of Bayesian analysis is the calculation of Bayes factors, which overcome many of the problems of traditional frequentist statistics [2] . One of these is the misinterpretation that Pvalues can be used to make claims of 'no effect' [3] [4] [5] . P-values signal the extremeness of the data under the assumption of the null hypothesis and so only tell us the probability of a test statistic at least as extreme as the one observed [6] . Thus, a P > 0.05 may reflect evidence for 'no effect' or data insensitivity, i.e. a failure to distinguish the null hypothesis from the alternative because, for example, the standard error (SE) is high.
Bayes factors are the ratio of the (average) likelihood of two hypotheses being correct given a set of data. When evaluating interventions, the two hypotheses are typically H 1 : that the intervention had a desired effect (for a given range of plausible sizes), or within a certain range, versus H 0 : that it had no effect. Thus, a Bayes factor is equivalent to a likelihood ratio [7] (averaged over different plausible effect sizes) and thus is often denoted as:
Bayes Factor¼ likelihood of data given H 1 likelihood of data given H 0 ¼ P D H 1 j ð Þ P D H 0 j ð Þ which simply represents the probability of the data (D) given the alternative hypothesis divided by the probability of the data given the null hypothesis. The use of Bayes factors has become more feasible in recent years following the development of online calculators [8] and R code [9, 10] . Conventional cut-offs for the interpretation of Bayes factors depend typically upon those set by Jeffreys [2] in the 1930s, with a Bayes factor greater than 3, or else less than ⅓, representing sufficient evidence to be taken note of for the experimental and null hypotheses, respectively; while values between approximately ⅓ and 3 indicate that the data are insensitive (see Table 1 ).
This paper uses a set of randomized trials in the field of addiction to examine whether, and in what way, the conclusions may have been different had the authors calculated Bayes factors in their analyses. This should be useful in future research to assess whether and when to use this form of analysis.
CALCULATING BAYES FACTORS
Several software packages are available including an online calculator developed by Zoltan Dienes (http://www.lifesci. sussex.ac.uk/home/Zoltan_Dienes/inference/Bayes.htm) and a modified version by John Christie using R code, which allows one to adjust the quality of the estimation [9, 10] .
Both approaches require the specification of an expected effect size (i.e. a plausible range of predicted values based on previous studies, judgement or clinical significance), the published effect size (e.g. mean difference or log odds ratio) and standard error of this parameter. They also both assume that the sampling distribution of the parameter estimate is distributed normally (hence the need to use the natural logs of odds ratios). The natural log of the odds ratio is approximately normally distributed with known standard error given by ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi ffi
, where A is the number of individuals in the experimental condition with the outcome of interest, B is the number of individuals in the experimental condition without the outcome of interest and C and D reflect the number of individuals with and without the outcome of interest in the control condition respectively (i.e. odds ratio = (A/B)/(C/D)), provided that these numbers are not very small. For adjusted odds ratios, and/or where standard errors (SE) are not reported, 95% confidence intervals (CI) can be used to derive the standard error {i.e. [LN(upper confidence interval)-LN(lower confidence interval)]/3.92}.
In instances where the primary outcome measure is a continuous variable, SEs can be derived for mean differences or regression coefficients (β) either using the standard formula for the SE of mean difference, i.e. [ A worked example, using the calculator associated with Dienes, can be found in Supporting information, Appendix 1.
Others have advocated alternative methods of computing Bayes factors, including the Jeffreys-Zellner-Siow (JZS) t-test [4, 12] , which can be implemented in R [13, 14] (see Dienes & McLatchie, submitted, for comparison). Moves have also been made towards full Bayesian modelling, which requires a much more advanced knowledge of R or specialist software packages, and is beyond the scope of the current paper (e.g. WinBUGS) [3, 11] .
METHODS
Bayes factors were calculated for 12 randomized controlled trials published in the first six issues of Addiction in 2013 (between January and June). Effect sizes, SEs, P-values and the main conclusions drawn by the authors were extracted from the papers for both primary and main secondary outcomes. Studies are generallyonly powered to detect estimated differences between experimental and control groups for the primary outcome, and thus Bayes factors may be particularly useful for secondary analyses [15, 16] . Concerns have been raised previously regarding the interpretation of nonsignificant findings for sensitivity analyses [15, 16] .
Adjusted effect sizes (where available) and those reported at the longest point of follow-up were used. Bayes factors were calculated using the online calculator provided by Dienes [8] and the modified version using R code by Christie [9, 10] . Predicted values for the effect size or population standard deviation (SD) were based on previous studies (see Table 2 ). Additional sensitivity analyses were run to assess the effect of using higher and lower values. The chosen range was based either on the reported CI of Very strong evidence for the null hypothesis < 1/100
Extreme evidence for the null hypothesis
The original label for 3 < Bayes factor < 10 was 'substantial evidence'. Lee & Wagenmakers changed it to moderate, as they thought the original label sounded too decisive [3, 11] . Gustafson [30] Interest circle calls waiting time reduction while interest circle calls had a slight increase, but these two groups' changes were not statistically significant. . None of the groups showed significant improvement in retention for the 6-month intervention period (Table 3a) , or the entire intervention and sustainability period ( Moderate evidence for experimental hypothesis P = primary outcome; S = secondary outcome; *significant at P < 0.05; **significant at P < 0.01; ***significant at P < 0.001; RaR = rate ratio; RR = relative risk; OR = odds ratio; MD = mean difference; the predicted effect size selected from previous publications or, when not available, the opinion of the lead author as to what would be a plausible effect. When specifying the predicted effect, we used a 'half normal distribution' whose peak was at 0 (no effect) and extending upwards with a SD equal to the expected effect size. This represents a hypothesis that the intervention had at least some positive effect, with the effect being more likely to be smaller than larger. This is a conservative approach to prediction. Another approach would be to specify the hypothesis as a uniform distribution between 0 (or a minimally clinically significant value) and a plausible upper bound. Given that none of the authors of the studies reviewed indicated what they considered to be a clinically meaningful effect or a plausible upper bound for the effect size, we took the conservative approach.
RESULTS
Of the 12 studies, 55 non-significant effects and 20 significant effects were reported. For each of these, three Bayes factors were calculated: one based on an expected population SD (identified from previous studies) and two based on a range of values around the expected population SD (identified from previous studies or based on expert opinion). Thus, a total of 75 Bayes factors were calculated in the main analysis and 150 Bayes factors were derived in the sensitivity analysis (see Table 2 ).
Fifty-six per cent (n = 42) of the Bayes factors were between ⅓ and 3; 14.7% (n = 11) were < ⅓ and 29.3% (n = 22) were > 3. When considering only the nonsignificant findings (n = 55), 20.0% (n = 11) of Bayes factors were < ⅓ and 3.6% (n = 2) were > 3. The other 76.4% (n = 42) of Bayes factors were between ⅓ and 3. Of these, 26 were in the direction of there being an effect (Bayes factor > 1 and < 3); 12 tended to favour the hypothesis of no effect (Bayes factor < 1 and > ⅓); and for four there was no evidence either way (Bayes factor = 1).
In sensitivity analyses, 13.3% of Bayes factors were < ⅓ (n = 20), 62.7% (n = 94) were between ⅓ and 3 and 24.0% (n = 36) were >3, showing good consistency with the main results.
Authors either decided not to discuss results where P > 0.05, to report them as non-significant and/or to state that no association was found. Good concordance was noted between the online calculator [8] and the adapted R code [9] , except for those Bayes factors that indicated extreme evidence for the experimental hypothesis.
DISCUSSION
Only ⅕ of all non-significant findings provided support for the hypothesis of no effect, while nearly ⅔ of the Bayes factors indicated data insensitivity. Thus, reporting 'no difference' between conditions or lack of associations was appropriate for only a small number of papers. A minority of Bayes factors for the non-significant effects also supported the experimental hypothesis; this tended to occur with Pvalues close to statistical significance.
The development of online calculators and R code [9, 10] means that researchers in the addiction field can calculate Bayes factors easily to include as an adjunct to traditional frequentist results. The requirement to specify the experimental hypothesis means that scientific judgement is needed. This is a common criticism of Bayesian type methods [17] , but it can also be a potential strength, because it forces researchers to be specific about what it is they are testing. Moreover, if there are differences of view about what may be plausible values of the effect size, it is a simple matter to conduct sensitivity analyses to assess what, if any, difference this makes. As a rule of thumb, if one is interested in a clinically relevant range then the uniform distribution can be specified; alternatively, one can use a half-normal distribution with the peak at 0 if one is interested in any effect at all and has little confidence in the probable value. To prevent researcher bias, pre-specified analysis plans may be published which detail the method which will be used to calculate Bayes factors, the cut-off values for interpretation and the plausible effect size which is expected.
The findings of this review show that researchers should avoid the use of terms such as 'no difference' or 'lack of associations' for P-values > 0.05, unless a Bayes factor < 0.3 is also found. Otherwise null findings should be framed as 'the findings were inconclusive as to whether or not a difference/association was present', or some similar wording. This is now encouraged practice by the Addiction journal [1] . Researchers may also wish to use Bayes factors in order to quantify the evidence for the experimental hypothesis (i.e. moderate, strong, very strong and extreme) and/or use such a calculation as a stopping rule for data collection [18] . For ethical and perhaps financial reasons interim analyses are often planned for randomized trials, with early stopping occurring if there is demonstrated efficacy, the intervention is harmful or there is no beneficial effect. P-values cannot inform about us about the latter; in contrast, a Bayes factor indicating data insensitivity would suggest further recruitment, while a Bayes factor indicating evidence for the null hypothesis may point towards early termination.
Note that the methods used to derive Bayes factors in this paper did not cover all the possibilities. More advanced Bayesian hierarchical modelling (BHM) [11] , implemented in R and winBUGS, allows a wider range of distributions, e.g. gamma, Poisson, binomial and negative binomial.
